Skip to contentSkip to filters

We use cookies for analytics.

20 results

Newest first

Behavioral, molecular and cellular effects of low-dose CBD administration in a chronic stress-induced major depression mouse model

Sara Borràs Pernas, Anna Sancho-Balsells, Daniel Del Toro, Albert Giralt · FENS Forum 2024

Major Depressive Disorder (MDD) is a prevalent, persistent and severe psychiatric condition characterized by persistent feelings of depression, anhedonia, and occasional suicidal thoughts, with stress identified as a major trigger. Previous research from our lab has shown changes in mouse emotional and cognitive behavior, and cellular and molecular alterations in some brain areas such as hippocampus, striatum and prefrontal cortex. Nevertheless, the mechanism underlying depression remain elusive, and so, an effective treatment. To tackle this issue, cannabidiol (CBD) treatment has emerged as a

ePoster · Neuroscience

Pre-clinical studies on drug addiction and relapse often overlooked volitional social interactions, which are of critical importance in human addiction. Recently, it has been demonstrated that social choice-based voluntary abstinence in rats attenuates the emergence of incubation of methamphetamine (Meth) craving relative to rats subjected to a forced abstinence. In the current study we investigated the molecular mechanisms by which social choice-based voluntary abstinence prevents the incubation of craving. An important mechanism driving cue-induced craving from psychostimulants in forced abs

ePoster · Neuroscience

Evolution of the psychiatric phenotype in the early stages of a Huntington's disease preclinical model

Baptiste Dayre, Katleen Pinchaud, Peter Vanhoutte, Sandrine Betuing · FENS Forum 2024

…HD mainly targets the medium spiny neurons of the striatum and more broadly the corticostriatal pathway, but other brain areas, such as the hippocampus, are also affected at more advanced stages of the disease. These deregulations are responsible for a triad of symtoms, consisting in cognitive and psychiatric symptoms that occur prior to the

ePoster · Neuroscience

Are mitochondria a missing link between arginase 2 loss and Huntington’s disease pathogenesis?

Martyna Podgajna, Magdalena Gewartowska, Aleksandra Kaczynska et al. · FENS Forum 2024

Arginase 2 (Arg2), an arginine-metabolizing, mitochondrial enzyme, has been recently found to be enriched in the striatum, and progressive loss of Arg2 has been proposed as a potential factor contributing to the pathogenesis of Huntington’s disease (HD), a disorder primarily involving this region of the brain. Although direct metabolic role of Arg2 is well established, the importance of this enzyme for striatal function and dysfunction is not known. The purpose of this work was to identify cellular pathways potentially controlled by Arg2 in the striatum. In our experiments, we have used wild-t

ePoster · Molecular Neuroscience

Modulation of 5-HT4R affects L-DOPA-induced dyskinesia in unilaterally 6-OHDA lesioned mice

Demetra Ballardin, Leila Makrini-Maleville, Alexander Seper et al. · FENS Forum 2024

Parkinson’s disease is caused by the selective loss of the dopaminergic neurons of the Substantia Nigra pars compacta and, consequently, striatal dopamine depletion. In Parkinson’s disease therapy, dopamine loss is counteracted by the administration of the dopamine precursor L-DOPA, which is initially effective in ameliorating motor symptoms, but over time it leads to a burdening side effect of uncontrollable jerky movements, termed L-DOPA-induced dyskinesia. To date, no efficient treatment for dyskinesia exists. The dopaminergic and serotonergic systems are intrinsically linked, and a role ha

ePoster · Neuroscience

Molecular profiling of Arc neuronal ensembles supporting the encoding of drug-context associations

Marine Salery, Arthur Godino, Yu Qing Xu et al. · FENS Forum 2024

…populations of concomitantly activated neurons defining drug-recruited ensembles. In this study, we explore the dynamics of recruitment of these ensembles through the encoding, strengthening and expression of cocaine-context associative memories. Additionally, we characterize the intrinsic (phenotypical) or acquired (plastic) cellular properties that

ePoster · Neuroscience

Neuropathology of the striatum in X-linked dystonia parkinsonism

Oliver Burnett, Adelie. Y. S Tan, Christine. J Arasaratnam et al. · FENS Forum 2024

X-linked dystonia-parkinsonism (XDP) is a recessive neurodegenerative disease endemic to Panay, Philippines. The XDP striatum is notably reported to undergo significant atrophy, neuronal loss, and astrogliosis. However, detailed neuropathological studies characterising the human XDP striatum are limited.To advance our understanding of the human XDP striatum, immunohistochemistry coupled with automated analysis was conducted on post-mortem striatal tissue from 12 XDP and 5 age-matched neurologically normal cases to detail (1) the neurochemical architecture and (2) neuronal and glial populations

ePoster · Neuroscience

The nucleus accumbens (NAc), a central hub in reward processing, intricately modulates emotional behaviours, including anxiety. A compound derived from the metabolization of polyphenols by the microbiota, mitobooster (MB) has been previously shown to improve mitochondrial function by promoting turnover of the dysfunctional mitochondria. In this study, we aimed to understand the effect of MB treatment in outbred rats that show high anxious-like behaviour. First, animals were grouped by their trait anxiety based on the amount of time spent in the open arms in the elevated plus maze test, and the

ePoster · Neuroscience

P2Y1 receptor participates in dopaminergic neurodegeneration in a rat model of Parkinson’s disease

Roberta Andrejew, Ágatha Oliveira-Giacomelli, Juliana Baranova et al. · FENS Forum 2024

The neurodegenerative process in Parkinson’s disease involves exacerbated inflammation with the participation of astrocytes. The P2Y1 receptor (P2Y1R) is a purinergic receptor predominantly expressed in astrocytes, regulating their activity, proliferation, and glutamate release. Therefore, our investigation explores whether the P2Y1R contributes to dopaminergic neuron degeneration, potentially via astrocytic involvement. To study dopaminergic degeneration, we injected 9 µg 6-hydroxydopamine into the right striatum (STR) of male Sprague-Dawley rats aged 6-8 weeks (ethical approval: 167/2019). D

ePoster · Neuroscience

Prediction and prevention of compulsive behaviors by closed-loop optogenetic recruitment of striatal interneurons

Eric Burguiere, Lizbeth Mondragon-Gonzalez, Christiane Schreiweis · FENS Forum 2024

…iare striatal parvalbumin (PV) interneurons which exert a powerful feedforward inhibition on medium spiny neurons. To investigate the role of PV interneurons in regulating aberrant striatal activity observed in repetitive behaviors, we used the Sapap3 mutant mice, which exhibit excessive self-grooming. Using optogenetics activation of PV int

ePoster · Neuroscience

Role of GluK1-containing kainate receptors in the development of cortico-striatal projections

Margarita Komarova, Patricia Seja, Julia Glukhova et al. · FENS Forum 2024

Kainate receptors are ionotropic glutamate receptors, involved in modulation of synaptic transmission in developing and adult brain. Genetic disruption of all five kainate receptor subunits reduces cortico-striatal synaptic connectivity and leads to OCD-related pathological behavior. The aim of the project is to evaluate if the OCD-like pathology arises due to the deficit in the development of cortico-striatal projections due to the lack of the kainate receptor subunit 1 (GluK1). We characterized the expression of GluK1 during the development of the cortico-striatal circuitry using immunohisto

ePoster · Neuroscience

Role of glycine receptors in the striatal network

Neha Prasanna, Bert Brône, Serge Schiffmann · FENS Forum 2024

…shown that besides GABA receptors, Medium Spiny Neurons (MSN), the projection neurons of the striatum, express functional chloride permeable GlyR, at adulthood, with α2 as the agonist bindin

ePoster · Neuroscience

Unraveling glutamatergic dysregulation in RARβ null mice striatal synapses and its implications in neurological disorders

Hanna Semaan, Jean-Marc Strub, Christine Schaeffer-Reiss, Wojciech Krezel · FENS Forum 2024

…web of signaling pathways among its neurons. At the heart of this neural symphony is glutamatergic signaling.Glutamatergic control of striatal activity is essential for several brain functions.Abnormal glutamatergic signaling is associated with several pathological conditions including Huntington’s disease (HD), a rare neurological disease marked by striatal dysfunction and degeneration.Compromised retinoic acid receptor beta (RARβ) signaling observed in the striatum of HD patients and mice models has been suggested to critically contribu

ePoster · Neuroscience

Off-policy learning in the basal ganglia

Ashok Litwin-Kumar · Columbia University, New York

…that predicts tuning of dopamine neurons to a quantity we call "action surprise," in addition to reward prediction error. In the same model, an implementation of learning from a motor efference copy also predicts a novel

Wed, May 3, 2023 · 05:00 UTC

Seminar · Computational Neuroscience

…However, observed coactivation of neurons initiating the two pathways, striatal direct (dMSNs) and indirect (iMSNs) medium spiny neurons, has called this view into question. Here we study these circuits in mice performing an interval categorization task that requires a series of self-initiated and cued actions, and critically, a sustained period of dynamic action suppression. While movement produced similar activation of iMSNs and dMSNs in sensorimotor, dorsolateral

ePoster · Neuroscience

Exploration of learning by dopamine D1 and D2 receptors by a spiking network model of the basal ganglia

Carlos Enrique Gutierrez, Jean Lienard, Benoît Girard et al. · COSYNE 2022

…Striatal medium spiny neurons (MSN) were classified based on the expression of dopamine D1 and D2 receptors. We implemented spike-timing dependent plasticity and structural parameters: i) the asymmetry of connections between MSN’s; and ii) the overlap between direct and indirect pathways. In action-selection simulations, we assume

ePoster · Computational Neuroscience

Medium-spiny neurons (MSNs) in the striatum are required for interval timing, or the estimation of the time over several seconds via a motor response. We and others have shown that striatal MSNs can encode the duration of temporal intervals via time-dependent ramping activity, progressive monotonic changes in firing rate preceding behaviorally salient points in time. Here, we investigated how timing-related activity within striatal ensembles changes with experience. We leveraged a rodent-optimized interval timing task in which mice ‘switch’ response ports after an amount of time has passed

Wed, Feb 17, 2021 · 04:00 UTC

Seminar · Behavioral Neuroscience